Copyright © 2000 by the European Society of Cardiology.
Inter-regional differences and outcome in unstable angina. Analysis of the International ESSENCE trial
a Department of Cardiology, The Royal Infirmary, Edinburgh, U.K.
b The Terrence Donnelly Heart Centre, Division of Cardiology, St Michael's Hospital, University of Toronto, Toronto, Canada
c Rhône-Poulenc Rorer, Cardiovascular Research Department, Antony Cedex, France
d Division of Cardiology, MCP-Hahnemann School of Medicine, Philadelphia, U.S.A.
revised September 25, 1999; accepted October 6, 1999
Abstract
Aims Worldwide there is a large variation in outcome (death, myocardial infarction and recurrent myocardial infarction) in patients with unstable angina or non-Q wave myocardial infarction. These variations may be explained by differences in characteristics of the presenting patients. Here we describe differences in patient presentation, treatment protocols and outcome and we investigate their relationship using data from the ESSENCE (Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-wave Coronary Events) trial.
Methods A total of 2981 patients from six countries which enrolled more than 100 patients were included in the present analysis: United States, Canada, Argentina, France, the Netherlands and United Kingdom. Logistic regression analysis was performed to determine the effect of baseline characteristics on regional outcome.
Results At day 30, the lowest triple end-point rate, irrespective of study drug treatment, was noted in the Netherlands (18·9%) and the highest in Argentina (30·5%). A model including the variables age
65 years, prior angina, diabetes, prior aspirin use, ECG changes at baseline and diagnosis of non-Q wave myocardial infarction and dummy variables for Argentina and France resulted in concordance of about 60%.
Conclusions Inter-regional differences in outcome in unstable angina and non-Q wave myocardial infarction patients can reasonably well be explained by differences in patient characteristics. However, other so far unidentified variables present in Argentina and France also contributed to differences in outcome and their effect warrants further investigation.
Key Words: Unstable angina, non-Q wave myocardial infarction, ESSENCE, low molecular weight heparin, enoxaparin, regional differences
f1 Correspondence: Professor Keith A. A. Fox, Department of Cardiology, The Royal Infirmary, Edinburgh EH3 9YW, U.K.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
P. A. Poole-Wilson Global Differences in the Outcome of Heart Failure: Implications for Clinical Practice J. Am. Coll. Cardiol., November 11, 2008; 52(20): 1649 - 1651. [Full Text] [PDF] |
||||
![]() |
A. Orlandini, R. Diaz, D. Wojdyla, K. Pieper, F. Van de Werf, C. B. Granger, R. A. Harrington, E. Boersma, R. M. Califf, P. Armstrong, et al. Outcomes of patients in clinical trials with ST-segment elevation myocardial infarction among countries with different gross national incomes Eur. Heart J., March 1, 2006; 27(5): 527 - 533. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Kaul, L K Newby, Y Fu, D B Mark, S G Goodman, G S Wagner, R A Harrington, C B Granger, F Van de Werf, E M Ohman, et al. Relation between baseline risk and treatment decisions in non-ST elevation acute coronary syndromes: an examination of international practice patterns Heart, July 1, 2005; 91(7): 876 - 881. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-C. Chang, W. K Midodzi, C. M Westerhout, E. Boersma, J. Cooper, E. S Barnathan, M. L Simoons, L. Wallentin, E M. Ohman, P. W Armstrong, et al. Are international differences in the outcomes of acute coronary syndromes apparent or real? A multilevel analysis J Epidemiol Community Health, May 1, 2005; 59(5): 427 - 433. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M Kramer, L.K. Newby, W.-C. Chang, R.J. Simes, F. Van de Werf, C. B Granger, K. L Lee, H. D White, L. S Piegas, E. J Topol, et al. International variation in the use of evidence-based medicines for acute coronary syndromes Eur. Heart J., December 1, 2003; 24(23): 2133 - 2141. [Abstract] [Full Text] [PDF] |
||||
![]() |
E P Gurfinkel, G Bozovich, and B Mautner International comparison of mortality rates in patients with non-ST elevation acute coronary events Heart, September 1, 2003; 89(9): 1083 - 1084. [Full Text] [PDF] |
||||
![]() |
P. Gabriel Steg, B. Iung, L. J Feldman, A. P Maggioni, U. Keil, J. Deckers, D. Cokkinos, K. A.A Fox, and for the ENACT investigators Determinants of use and outcomes of invasive coronary procedures in acute coronary syndromes: results from ENACT Eur. Heart J., April 1, 2003; 24(7): 613 - 622. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. A. Fox, S. G. Goodman, W. Klein, D. Brieger, P. G. Steg, O. Dabbous, A. Avezum, and GRACE Investigators Management of acute coronary syndromes. Variations in practice and outcome. Findings from the Global Registry of Acute Coronary Events (GRACE) Eur. Heart J., August 1, 2002; 23(15): 1177 - 1189. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. de Lorgeril, P. Salen, F. Paillard, F. Laporte, F. Boucher, and J. de Leiris Mediterranean diet and the French paradox: Two distinct biogeographic concepts for one consolidated scientific theory on the role of nutrition in coronary heart disease Cardiovasc Res, June 1, 2002; 54(3): 503 - 515. [Full Text] [PDF] |
||||
![]() |
R.P Giugliano, J Llevadot, R.G Wilcox, E.P Gurfinkel, C.H McCabe, A Charlesworth, S.L Thompson, E.M Antman, E Braunwald, and for the In TIME II Investigators Geographic variation in patient and hospital characteristics, management, and clinical outcomes in ST-elevation myocardial infarction treated with fibrinolysis. Results from InTIME-II Eur. Heart J., September 2, 2001; 22(18): 1702 - 1715. [Abstract] [PDF] |
||||
![]() |
H. Rosolova and J. Simon Are the data on trends in case-fatality in patients with acute myocardial infarction observed in Scotland applicable across Europe? Eur. Heart J., June 2, 2001; 22(12): 979 - 980. [PDF] |
||||
![]() |
J.C. O'Shea and R.M. Calif Inter-regional differences in acute coronary syndrome trials Eur. Heart J., September 1, 2000; 21(17): 1397 - 1399. [PDF] |
||||




